Close Menu

NEW YORK (GenomeWeb) – Two law firms have filed class action lawsuits against Myriad Genetics on behalf of investors, alleging that the molecular diagnostic firm failed to accurately disclose how it billed Medicare and Medicaid for its myRisk Hereditary Cancer test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.